EXABS-185-TCL The Next Rational Therapeutic Regimen in Newly Diagnosed PTCL

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S85-S86
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	22
DOIs	https://doi.org/10.1016/S2152-2650(22)00674-7
State	Published - Oct 2022

Keywords

@article{a671084e7e424d02a977b889cd3692c4,

title = "EXABS-185-TCL The Next Rational Therapeutic Regimen in Newly Diagnosed PTCL",

keywords = "Peripheral T-cell lymphoma, anaplastic large cell lymphoma, angioimmunoblastic T-cell lymphoma, azacitidine, duvelisib",

author = "Neha Mehta-Shah",

year = "2022",

month = oct,

doi = "10.1016/S2152-2650(22)00674-7",

language = "English",

volume = "22",

pages = "S85--S86",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

}

TY - JOUR

T1 - EXABS-185-TCL The Next Rational Therapeutic Regimen in Newly Diagnosed PTCL

AU - Mehta-Shah, Neha

PY - 2022/10

Y1 - 2022/10

KW - Peripheral T-cell lymphoma

KW - anaplastic large cell lymphoma

KW - angioimmunoblastic T-cell lymphoma

KW - azacitidine

KW - duvelisib

UR - http://www.scopus.com/inward/record.url?scp=85138183560&partnerID=8YFLogxK

U2 - 10.1016/S2152-2650(22)00674-7

DO - 10.1016/S2152-2650(22)00674-7

M3 - Article

C2 - 36164244

AN - SCOPUS:85138183560

SN - 2152-2650

VL - 22

SP - S85-S86

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

ER -